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Abstract
Articular cartilage is a dense extracellular matrix-rich tissue that degrades following chronic mechanical stress, resulting in
osteoarthritis (OA). The tissue has low intrinsic repair especially in aged and osteoarthritic joints. Here, we describe three
pro-regenerative factors; fibroblast growth factor 2 (FGF2), connective tissue growth factor, bound to transforming growth
factor-beta (CTGF-TGFβ), and hepatoma-derived growth factor (HDGF), that are rapidly released from the pericellular matrix
(PCM) of articular cartilage upon mechanical injury. All three growth factors bound heparan sulfate, and were displaced by
exogenous NaCl. We hypothesised that sodium, sequestered within the aggrecan-rich matrix, was freed by injurious
compression, thereby enhancing the bioavailability of pericellular growth factors. Indeed, growth factor release was
abrogated when cartilage aggrecan was depleted by IL-1 treatment, and in severely damaged human osteoarthritic cartilage.
A flux in free matrix sodium upon mechanical compression of cartilage was visualised by 23Na -MRI just below the articular
surface. This corresponded to a region of reduced tissue stiffness, measured by scanning acoustic microscopy and second
harmonic generation microscopy, and where Smad2/3 was phosphorylated upon cyclic compression. Our results describe a
novel intrinsic repair mechanism, controlled by matrix stiffness and mediated by the free sodium concentration, in which
heparan sulfate-bound growth factors are released from cartilage upon injurious load. They identify aggrecan as a depot for
sequestered sodium, explaining why osteoarthritic tissue loses its ability to repair. Treatments that restore matrix sodium
to allow appropriate release of growth factors upon load are predicted to enable intrinsic cartilage repair in OA.
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Significance Statement
Osteoarthritis is the most prevalent musculoskeletal disease, affecting 250 million people worldwide.1 We identify a novel
intrinsic repair response in cartilage, mediated by aggrecan-dependent sodium flux, and dependent upon matrix stiffness,
which results in the release of a cocktail of pro-regenerative growth factors after injury. Loss of aggrecan in late-stage
osteoarthritis prevents growth factor release and likely contributes to disease progression. Treatments that restore matrix
sodium in osteoarthritis may recover the intrinsic repair response to improve disease outcome.
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Introduction
Articular cartilage is a highly mechanosensitive tissue that over-
lies the ends of bone in all articulating joints. It is predomi-
nantly composed of extracellular matrix, with the remaining
tissue containing sparsely distributed cells (chondrocytes) that
constitute 5–10% of the tissue by volume. Articular cartilage
contains an abundance of type II collagen, a fibrillar collagen
responsible for providing tensile strength to the tissue, and pro-
teoglycans. The most abundant proteoglycan of articular carti-
lage is aggrecan, to whose core protein are attached ∼100 chon-
droitin sulfate glyscosaminoglycan (GAG) chains2, which gen-
erate a net negative fixed charge to the tissue. This negative
charge contributes to the osmotic retention of water in the tis-
sue by attracting sodium cations, and provides intermolecu-
lar electrostatic repulsion between GAGs, contributing to tissue
stiffness and elasticity. The aggrecan-rich extracellular matrix
is divided into the territorial matrix (TM) and interterritorial
matrix (ITM) and these are separated from the cell by a dis-
tinct region of matrix termed the pericellular matrix (PCM),
which is rich in collagen VI and the heparan sulfate proteoglycan
perlecan.3
Loss of aggrecan is an early pathological feature of cartilage
matrix breakdown that occurs in osteoarthritis (OA), a disease
estimated to affect over 250 million people worldwide,4 and a
leading cause of disability and societal burden. Other disease
features of the OA joint include synovial hypertrophy, osteo-
phyte formation, and subchondral bone sclerosis. Degradation
of aggrecan can be detected histologically using cationic dyes,
as well as in patients in vivo by sodium-MRI imaging.5 A num-
ber of pathogenic mechanisms contribute to the development
of OA, which can be broadly divided into those that drive pro-
teolytic degradation of the matrix and those that suppress the
intrinsic repair of the tissue. Both are closely linked to the two
major aetiological factors in disease; abnormal mechanical joint
loading and ageing.
In exploring the response of articular cartilage to mechan-
ical stress, our group has observed that sequestered matrix-
bound growth factors are released from the PCM of cartilage
following mechanical injury. The best characterised of these
is fibroblast growth factor 2 (FGF2), which is chondroprotec-
tive in vivo in multiple animal models of OA.6–12 The second
molecule identified was connective tissue growth factor (CTGF),
which is in a covalently bound complex with latent transform-
ing growth factor beta (TGFβ).13 When the latent complex is
released from cartilage upon injury, latent TGFβ is activated by
binding to the cell surface receptor TGFβR3 13. TGFβ is a strong
chondrogenic growth factor14,15 and is implicated in intrinsic tis-
sue repair responses elsewhere in the body.16–18 TGFβ and FGF2
exhibit binding affinities to heparin and heparan sulfate.19 In
our previous studies, both growth factors were released rapidly
upon injury (within 5 min), and this was independent of cell
viability.13,20
In this study, we characterise a third growth factor released
upon cartilage injury, hepatoma-derived growth factor (HDGF).
We reveal the common mechanism by which all three growth




Porcine articular cartilage was from the metacarpophalangeal
joint for injury and recutting experiments, or from the medial
tibial plateau of the knee joint for imaging experiments, of
7-month-old pigs obtained from an abattoir after slaughter.
Human articular cartilage was obtained from knee arthroplasty
surgery of osteoarthritic patients.
Cartilage Injury
For recutting injury experiments, uniform cartilage discs were
explanted using a 4 mm biopsy punch (Stiefel #BI1500). Explants
were rested in serum-free Dulbecco’s Modified Eagle’s medium
(DMEM) for 48 h. Rested explants remained uncut (rested) or
were injured (recut into four pieces by cutting twice with a
scalpel (Swann-Morton, 15 blade) for 30 min, or specified time,
in serum-free DMEM, after which time the conditioned medium
was removed for immediate use or stored at –20◦C.
Dead cartilage was freeze-thawed after dissection and
washed thoroughly before recutting experiments. Cartilage
injured at 4◦C or in the presence of inhibitors were pre-treated
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(recut), using batimastat from AbCam (ab142087) or protease
inhibitor from Roche/Sigma (#4 693 132 001). Recutting exper-
iments in the presence of exogenous NaCl were conducted by
placing explants in serum-free DMEM containing added NaCl to
a total of 137 mM (1x), 274 mM (2x), 548 mM (4x), 822 mM (6x).
Explants were cut into smaller pieces (approx. 1x1x1mm). After
15 min, conditioned medium was removed for immediate use or
stored at –20◦C.
Aggrecan Depletion of Chondroitin Sulfate (Sodium
Depletion)
Uniform cartilage discs were explanted using a 4 mm biopsy
punch and rested in serum-free Dulbecco’s Modified Eagle’s
medium (DMEM) for 24 h. Explants were treated either
with serum-free DMEM or with serum-free DMEM containing
50 ng/ml interleukin-1 for 7 days. Medium was collected and
replenished every 24 h, and assessed for GAG release by DMMB
assay. After 7 days, recutting injury was performed as described,
or explants were stained with safranin O to assess fixed charge
density. Alternatively, after 7 days, explants were extracted
using a dissociative whole tissue lysis buffer (RIPA), or 2.5 M
NaCl.
Sodium 23MRI Loaded Imaging
Osteochondral cubes of 1 cm3 were dissected from the porcine
knee medial tibial plateau, then vacuum sealed and placed in
a custom-made compression cell. Imaging and spectroscopy
were conducted for both proton and sodium nuclei on a Bruker
9.4T Ultra-high field microimaging system. Samples were first
imaged uncompressed, then after compressive load to the carti-
lage surface (28% deformation), and finally after relaxation with
no compression. Loading in MRI experiments was performed
after placing samples into a custom-made compression cell.
The cartilage specimen was placed in the centre of the cell and
compressed using a screw-driven plunger entering the cell from
the top. The compression was released by returning the screw-
driven plunger into its original position. Compression was mon-
itored by proton MRI.
Anatomical images were acquired with home written gradi-
ent echo code (TopSpin3.2, Bruker, Germany) using dual tuned
1H/23Na microimaging coil to ensure proper co-registration of
anatomical and sodium images. Each anatomical imaging pro-
tocol was performed without slice selection in order to match
best sodium scan parameters. Time domain data were acquired
into 256×128 matrices and were processed using Prospa 3.2
(Magritek, Germany) to result in the magnitude images with
FOV = 19.52 mm2 and in plane image resolution of 76 μm2. Fur-
ther experimental details are reported in Supplementary meth-
ods.
Sodium imaging was performed after 1H scans. Localisa-
tion of free and bound sodium was performed with TopSpin 3.2
(Bruker, Germany) using a home written non-selective Gradi-
ent Echo (GE) MRI protocol. Bound sodium was visualised during
loading cycle by inserting multiple quantum filter (MQF) into GE
protocol before applying localising gradients. MQF time duration
was determined from a series of triple quantum filtered experi-
ments and set to the evolution time τ where the triple quantum
filtered signal was at maximum. Achieved in plane resolution
in sodium images was (117 × 0.109) μm2 for free and (62 × 86)
μm2 for bound sodium. Two dimensional (2D) 23Na MRS TQ TPPI
spectroscopy was performed during loading cycles in order to
determine changes in free and bound sodium levels upon com-
pression and relaxation. All details of these experiments and
analysis of the obtained spectra to yields fractions of sodium in
the free and bound states during the loading cycle are reported
in Supplementary methods.
Cartilage Depth Loaded Imaging
Porcine articular cartilage explants were taken from the pig knee
joint by a 4 mm biopsy punch (Stiefel #BI1500). Explants were
washed in serum-free DMEM and serum starved for 48 h. Car-
tilage explants were either cyclically loaded (0.1Hz) or rested in
serum free DMEM for 45 min at 37◦C and snap frozen in liquid
nitrogen. Frozen explants were mounted in optimal cutting tem-
perature compound (OCT) and cut by cryostat into 7 μm frozen
sections (through the full thickness) on Surgipath snowcoat Xtra
slides. Alternatively, rested porcine knee joint cartilage samples
were cut across specified depths for mass spectrometry analysis
or SAM and polarised light microscopy.
Sample Preparation for Mass Spectrometry Analysis
4M Gu-HCl tissue extracts of sectioned regions (from superfi-
cial zone towards the bone) were precipitated with ethanol (9:1)
overnight at 4◦C and collected after centrifugation at 13 200 g at
4◦C for 30 min. The precipitate was dissolved in 100 μL of buffer
(25 mM ammonium bicarbonate (AmBic), pH:7.8)/0,2% Rapigest
(Waters) reduced with 2mM DTT at 56◦C for 30 min on an orbital
shaker and alkylated with 8 mM iodoacetamide at room tem-
perature for 1 h in the dark. Trypsin digestion was performed
with 2 μg of trypsin gold (Promega, Madison, WI) at 37◦C on
a shaker for 16 h. Subsequently, samples were diluted to 200
μl with 1M AmBic and filtered through a 30 kDa filter (Pall Life
Sciences, Port Washington, NY) by centrifugation at 2060 x g for
8 min. The filter was then washed with an additional 100 μl 0.5
M AmBic buffer to optimize recovery. The filtrates were then
desalted using a reversed-phase C18 column (UltraMicro Spin
C18, The Nest group, Southborough, MA) according to the man-
ufacturer’s instructions.
Discovery Mass Spectrometry
The samples were analyzed on a quadrupole Orbitrap bench-
top mass spectrometer (Q ExactiveTM) (Thermo Fisher Scien-
tific, Waltham, WA) equipped with an Easy nano-LC 1000 system
(Thermo Scientific, Waltham MA). Separation was performed on
75 μm × 25 cm capillary columns (Acclaim PepmapTM RSLC, C18,
2 μm, 100 Å, Thermo Scientific, Waltham, WA). A spray volt-
age of +2000 V was used with a heated ion transfer setting of
275◦C for desolvation. On-line reversed-phase separation was
performed using a flow rate of 300 nl/min and a linear binary
gradient from 3% solvent B for 60 min to 35% solvent B, then to
90% solvent B for 5 min and finally isocratic 90% solvent B for
5 min. An MS scan (400–1200 m/z) was recorded in the Orbitrap
mass analyzer set at a resolution of 70 000 at 200 m/z, 1 × 10E6
automatic gain control (AGC) target and 100 ms maximum ion
injection time. The MS was followed by data-dependent collision
induced dissociation MS/MS scans at a resolution of 15 000 on
the 15 most intense multiply charged ions at 2 × 10E4 intensity
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Database Search
Identification was performed using the sus scrofa taxon-
omy (22 166 sequences) setting of the Uniprot database (Pro-
teome UP000008227) with Proteome Discoverer 2.5 (version
2.5.0.400, Thermo Scientific). The processing workflow consisted
of the following nodes: Spectrum recalibration; Minora Feature
detection; Spectrum Selector for spectra pre-processing (350–
5000 Da); Spectrum Properties Filter (S/N Threshold: 1.5); Spec-
trum Properties (charges 2–6); Sequest-HT search engine (Protein
Database: see above; Enzyme: Trypsin; Max. missed cleavage
sites: 2; Peptide length range 6–144 amino acids; Precursor mass
tolerance: 10 ppm; Fragment mass tolerance: 0.02 Da; Static
modification: cysteine carbamidomethylation; Dynamic mod-
ification: methionine and proline oxidation; INFERYS Rescor-
ing and Percolator for peptide validation (FDR < 1% based on
peptide q-value). Results were filtered to keep only the Mas-
ter protein and protein FDR < 1%. The quantification workflow
was based on protein abundance using top-3 peptide intensities
average allowing only unique peptides. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDE 55 partner repository with the dataset
identifier PXD023890.
Immunohistochemistry
Frozen tissue sections were fixed in methanol for 10 min,
blocked with 10% goat serum/PBS for 60 min at room temper-
ature, and incubated with anti-phospho-Smad2 antibody from
Cell Signaling (#138D4) (1:1000 dilution in goat serum) for 1 h at
room temperature. Sections were washed three times with PBS
and incubated with secondary Alexa 647-conjugated IgG, goat
anti rabbit antibody from Invitrogen (#A-31 852) for 1 h at room
temperature. After wash and mounting in 50% glycerol, flores-
cence signals were detected by Ultraview confocal microscopy
(Perkin-Elmer, x60 oil immersion lens).
Protein Analysis
Growth factor proteins were analysed in conditioned medium
and dissociative tissue extracts by Western blotting using anti-
HDGF from AbCam (ab131064), anti-CTGF from Santa Cruz (sc-
14 939), and anti-FGF2 from PeproTech (#500-P18). FGF2 in con-
ditioned medium was also analysed by FGF2 V-PLEX ELISA from
MSD (#K151MDD).
Scanning Acoustic Microscopy (SAM) Loaded Imaging
Loaded and rested porcine articular cartilage was sectioned to
5 microns thickness. Sections were air dried overnight onto a
charged glass slide. Sections were rehydrated and imaged under
SAM to measures acoustic wave speed, positively correlated to
tissue stiffness. Images were taken from the articular (STZ) to
the deep zone in normal and loaded samples to assess wave
speed across the tissue by sampling five boxed regions (50 ×
50 pixels) every 200 μm. The same tissue region was imaged by
polarised light microscopy.
Human Osteoarthritic Cartilage
Human osteoarthritic cartilage was macroscopically graded
for severity of disease by modified Outerbridge classification
(Grade 0; normal cartilage, Grade 1; cartilage with softening and
swelling, Grade 2; partial-thickness defect with superficial fis-
suring, Grade 3; deep fissuring, Grade 4; exposed subchondral
bone). Human osteoarthritic articular cartilage biopsies, with
assigned Outerbridge scores, were taken using a 4 mm biopsy
punch (injury) and placed in 200 μl serum-free DMEM. After
30 min the conditioned medium was removed and stored at –
20◦C, and explants were fully digested with 50 μg/ml proteinase
K and assessed for GAG content by DMMB assay. Alternatively,
explant matrix proteins were extracted with 2.5 M NaCl for
30 min, then total tissue protein extracted with a dissociative
lysis buffer (RIPA) for 1 h.
Polarization Sensitive SHG Imaging of Collagen Fibres
under Compression
Polarization sensitive Second Harmonic Generation (PSHG) was
used to investigate the collagen fibre realignments under com-
pressive load on the microscopic scale. The strength of the SHG
signal from collagen is highly dependent on the polarisation of
the laser fundamental with respect to the collagen fibre axis.
Therefore by taking a series of images at different polarization
angles, it is possible to extract detailed information on the col-
lagen organisation within the tissue on the microscopic scale.
This analysis provides two parameters, I2 and φ2, which describe
the collagen fibre organisation on the microscopic scale. φ2 is
the predominant collagen fibre orientation in a given pixel, and
I2 is a measure of the molecular organisation at a submicron
scale (I2 = 0 when the collagen fibre arrangement is isotropic,
and increasing values of I2 indicate a more parallel collagen fibre
arrangement). A full description of how the measurements are
taken and how the parameters I2 and φ2 are derived is given in 56.
1 mm thick sections of human articular cartilage with the under-
lying bone attached were compressed on a bespoke loading rig
which attached onto the stage of the multiphoton microscope
(Supplementary Figure S3), after compressive loading the sam-
ples were left for 30 min to equilibrate.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism ver-
sion 9.1.2, GraphPad Software, San Diego, California USA, ww
w.graphpad.com. Normality of data was tested with Shapiro–
Wilk normality test and equal variance was tested to determine
appropriate parametric or non-parametric tests within Prism.
Statistical methods are described in figure legends. (∗ = p<0.05,
∗∗ = p<0.01, ∗∗∗ = p<0.001, ∗∗∗∗ = p<0.0001).
Results
PCM Growth Factors, Including Hepatoma Derived
Growth Factor (HDGF) are Bound to Heparan Sulfate
and Released Rapidly upon Cartilage Injury
We previously identified HDGF from a proteomic analysis of
human isolated PCM (unpublished data) and tested whether
HDGF was released upon cartilage injury in a similar fashion
to release of FGF2 and CTGF. FGF2, CTGF, and HDGF were all
released from human knee cartilage within 30 min of recut-
ting injury (Figure 1A), and were not detected in the medium
of uninjured, rested cartilage explants. HDGF release into the
medium occurred largely within the first 5 min (Figure 1B). We
confirmed our previous observation of co-localisation of FGF2
and CTGF in the type VI collagen and perlecan-rich PCM (Figure
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Figure 1. Heparan sulfate-bound growth factors are released upon cartilage
injury. (A) Immunoblots of medium conditioned (30 min) by rested (48 h post dis-
section) or recut (Recut CM) human articular cartilage (representative of n = 3).
(B) Medium conditioned by rested and recut cartilage for 5 or 30 min (represen-
tative of n = 3). Recombinant HDGF (rHDGF). (C) confocal microscopy showing
co-immunolocalisation of type VI collagen/perlecan, perlecan/FGF2, and per-
lecan/CTGF (CCN2) in the PCM of human articular cartilage. Scale bar 30μm
(D) Porcine injury CM (recut) was passed through a heparin-agarose column
and eluted with 2.5M NaCl. Starting material (Recut CM), column flow through
(Heparin FT) and eluted fractions (NaCl Elution) were immunoblotted for CTGF,
HDGF, and FGF2 (representative of n = 3). (E) Rested porcine articular cartilage
was treated with 0, 0.1, or 1 mU/ml heparitinase I for 4 h and the medium
immunoblotted for growth factors (representative of n = 3). (F) Immunoblots of
FGF2, CTGF, and HDGF from rested or recut CM (30 min) from live or dead (three
cycles of freeze-thawing) porcine articular cartilage. (G) Porcine articular carti-
lage explants were pre-treated with 10 μm batimastat (MMP inhibitor) or with
protease inhibitor cocktail, or were incubated at 4◦C or 37◦C prior to recutting
(representative of n = 3).
by showing their depletion from the injury conditioned medium
(recut CM) on a heparin column, and elution with 2.5M NaCl
(Figure 1D). They were also released from articular cartilage fol-
lowing treatment with heparitinase (Figure 1E). The injurious
release of growth factors occurred irrespective of whether the
tissue was alive or dead (Figure 1F), at 4◦C or 37◦C, or after
pre-incubation with an inhibitor of matrix metalloproteases, or
a broad-spectrum protease inhibitor (Figure 1G). These results
suggested that there was a common mechanism of release
of PCM-bound growth factors upon cartilage injury, which did
not require viable cells or involve cell-dependent protease
activity.
Manipulation of Tissue Sodium Affects Growth Factor
Release Upon Cartilage Injury
As the interaction of heparin-bound growth factors with hep-
aran sulfate is ionic and the growth factors in injury CM were
displaced by elution from a heparin column with sodium chlo-
ride (Figure 1D), we hypothesised that growth factor release after
injury was dependent upon mobilisation of tissue sodium. This
hypothesis was supported by the fact that the PCM was devoid
of chondroitin sulfate (Figure 2A), indicating a cation gradient
from the aggrecan-rich territorial matrix to the PCM.
To test the hypothesis, we studied the injury response
after manipulating tissue sodium levels. Addition of exoge-
nous sodium chloride, at supraphysiological concentrations,
displaced HDGF and CTGF from cartilage in a concentration
dependent manner and enhanced the release of HDGF and CTGF
after injury (Figure 2B, C). Conversely, depletion of aggrecan from
cartilage following prolonged treatment with interleukin-1 (IL-
1), reduced the fixed charge of the tissue (Figure 2D) and abro-
gated the release of HDGF, CTGF, and FGF2 upon recutting (Figure
2E–H). The reduction in release upon injury occurred despite
there being no difference in total growth factor extracted from
untreated and IL-1 treated tissue (Figure 2I).
Bound Sodium is Mobilised Upon Cartilage
Compression
We next examined the effect of mechanical compression on
cartilage sodium mobilisation using multi-modal MRI methods
(Figure 3A). Porcine knee osteochondral plugs were imaged using
a Bruker AVANCE III 9.4T microimaging system at micron length
scales to obtain anatomical, free and bound sodium scans of
cartilage plugs during compressive loading. A strong sodium
signal was seen in the articular cartilage, but not subchon-
dral bone (Figure 3B). The MRI signal contribution from bound
sodium was determined by inserting a MQF before applying
localising gradients (Supplementary Figure S2). Tissue compres-
sion (28% strain) caused redistribution of both free and bound
sodium within articular cartilage (Figure 3B). Compression led
to a heterogeneous distribution in free sodium in the cartilage
matrix, specifically just below the superficial layer. Compression
reduced bound sodium levels, with partial restoration of these
levels upon relaxation of the cartilage. This was further con-
firmed by two dimensional 23Na TQTPPI spectroscopy (details
in supplementary–23Na MRS) where sodium signals in both free
and bound states are recorded, providing information about bulk
sodium levels in each state. Tissue compression caused a signif-
icant increase in free sodium of 46%, with a concomitant sig-
nificant decrease in the bound sodium fraction (F(2,9) = 9.709,
p = 0.0057) (Figure 3C). Upon relaxation of the tissue, the free
and bound sodium fractions were lower than in the compressed
state, with a tendency towards uncompressed levels.
Compression-Induced Growth Factor Release is
Preferentially in Areas of Low Matrix Stiffness
To explore further the possibility that regional differences exist
within the tissue, cyclically compressed porcine knee carti-
lage was examined by immunohistochemistry for evidence of
growth factor dependent cell activation. SMAD2 phosphoryla-
tion, indicative of TGFβ activation, was evident in the super-
ficial zone of cartilage from just below the articular surface
(between 50 and 300 μm from the surface) in compressed, but
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Figure 2. Changes in tissue NaCl affect injury-induced growth factor release. (A) Confocal microscopy delineating PCM (type VI collagen) and TM (type II collagen
and chondroitin sulfate (CS)), in human articular cartilage. (B) Western blot of CM (0–15 min) from rested and recut porcine articular cartilage generated in medium
with physiological NaCl (0.137 mM) or supraphysiological NaCl concentrations (2–6 fold). (C) Quantification for HDGF and CTGF (Two-Way ANOVA with Sidak multiple
comparisons compared to 1x NaCl, n = 3 biological replicates). (D–I) Aggrecan was depleted from articular cartilage by 7 day IL-1 treatment. (D) Safranin O staining
of porcine cartilage after 7 day. (E) Immunoblots of growth factors of rested and injury CM after recutting (0–15 min). (F–H) Quantification of western blots for HDGF,
CTGF, and FGF2, respectively (2-way ANOVA, n = 6,6,2 biological replicates, respectively). (I) Western blots of tissue extracts (2.5M NaCl or dissociative lysis buffer) of
control and IL-1-treated explants (representative experiment of four independent experiments). (∗ = p<0.05, ∗∗ = p<0.01, ∗∗∗ = p<0.001, ∗∗∗∗ = p<0.0001).
activation was not due to differences in the amount of growth
factor present in the tissue at different levels, as all three PCM
growth factors were identified throughout the deeper parts of
the uncompressed tissue by proteomic analysis (Figure 4D). Full
proteomic dataset of each cartilage layer shown in supplemen-
tary file and raw data available via ProteomeXchange with iden-
tifier PXD023890.
As the region of SMAD2 activation was not apparently lim-
ited by growth factor distribution within the tissue, we next
explored whether regional differences in tissue stiffness might
explain differential activation upon compression. SAM wave
speeds were recorded across the depth of the tissue in com-
pressed and non-compressed tissue sections. Variations in stiff-
ness through the depth of the tissue were observed, with the
highest stiffness (highest wave speed) in the most superficial
50 μm and a region of reduced stiffness below this from 50–350
μm, which became more evident upon compression (Figure 4E).
This region also contained a higher polarised light microscopy
signal, consistent with disordered collagen fibres in this region
(Figure 4F).
Differential stiffness and response to compression was fur-
ther investigated in human articular cartilage by second har-
monic generation (SHG), to explore the collagen organisation
and arrangement upon compression. Following compressive
load of the tissue (0–21% strain), a marked loss of tissue volume
was observed in the superficial zone (Figure 5A–D). This was pre-
dominantly in the superficial region (Figure 5A, upper box), asso-
ciated reorganisation of the collagen fibre orientation (Figure
5E). In contrast, compression of the tissue led to no discernible
volume loss in the deep region (Figure 5A lower box, Figure 5F–
H), with no change in the collagen orientation (Figure 5I). In
both regions of interest, the submicron organisation parameter
I2, which represents the degree of order of individual collagen
fibrils within a focal spot, remained constant (data not shown).
Taken together, these data confirm region-specific difference in
tissue stiffness and response to compression in human carti-
lage, similar to that seen in pig.
Severely Damaged Osteoarthritic Tissue Exhibits
Impaired Release of Heparan Sulfate Bound Growth
Factors After Injury
Proteolytic degradation of aggrecan in OA occurs through the
actions of aggrecanases 21–23 and results in a reduction of the
fixed charge density of the tissue reflected by the loss of safranin
O staining (Figure 6A). We explored whether release of growth
factors after injury was blunted in OA and whether it was depen-
dent upon severity of disease in an aggrecan-dependent man-
ner. Cartilage biopsies were taken from human osteoarthritic
cartilage obtained from knee arthroplasty surgery (Figure 6B)
and scored for macroscopic disease severity using the Out-
erbridge classification. Proteoglycan content (as assessed by
amount of GAG) inversely correlated with Outerbridge score
(Figure 6C), confirming that severe macroscopic damage was
associated with reduced GAG (aggrecan) content. Uniform
biopsy punches (matched by wet weight) from severely diseased
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Figure 3. Sodium is reversibly mobilised from bound stores upon cartilage com-
pression. (A) Schematic of tibial plateau osteochondral plugs for 1H (anatomi-
cal) and 23Na (free and bound) MRI performed at microscale resolution in initial
(uncompressed), compressed (28% strain), and relaxed states. All images were
recorded at steady state. (B) Anatomical, free and bound sodium scans overlaid
with corresponding anatomical scans of vacuum-sealed porcine osteochondral
plugs during loading cycle depicted in A. (C) Free and bound sodium fractions
(n = 4) quantified with 2D TQTPPI 23Na spectroscopy in the initial, compressed,
and relaxed states as depicted in A. One-Way ANOVA with Tukey multiple com-
parisons (∗ = p<0.05, ∗∗ = p<0.01).
CTGF, and FGF2 upon injury compared with biopsies taken from
relatively undamaged regions of the same joint (Outerbridge
score 0–1) (Figure 6E–H). This was not due to reduced growth fac-
tor content as protein extracted from the matrix with 2.5 M NaCl
indicated that the more damaged cartilage contained higher Na-
extractable growth factor compared with tissue with mild dis-
ease (Figure 6I–L).
Discussion
To date, our group has identified three growth factors that
are released rapidly following mechanical injury of articular
Figure 4. TGFβ/CTGF mediated SMAD2 activation occurs after cyclical compres-
sion in a region of cartilage with low tissue stiffness. Porcine articular cartilage
was (A) cyclically loaded for 45 min or (B) left unloaded. (A, B) Coronal sections
perpendicular to the articular surface were immunostained for phosphorylated
SMAD2 (green) and (C) quantified (n = 6 separate experiments). Nuclei were
counterstained with propidium iodide. (D) Slices of uncompressed articular car-
tilage, parallel with the articular surface were removed by cryosection and anal-
ysed by proteomics. (E) SAM was performed across the depth of porcine knee
cartilage sections, where wavespeed denotes tissue stiffness from the surface
(left) to the deep zone (right). (F) Articular cartilage sections were imaged for
collagen alignment by polarised light microscopy.
cartilage.3,13,20 Here, we characterise the release of HDGF, a
lesser known heparan sulfate bound growth factor, which we
had previously identified in a proteomic analysis of the carti-
lage PCM (unpublished data). Like CTGF and FGF2, HDGF was
released rapidly, in a cell-independent manner, from a heparan
sulfate bound matrix store. Commonality between the three
growth factors, in terms of release by injury and sequestration
on heparan sulfate within the PCM, suggested a common mech-
anism of release.
Three distinct properties of cartilage led us to hypothesise
that release upon injury was due to a shift in the matrix sodium
concentration. Firstly, the extracellular sodium content in car-
tilage is high compared with other tissues, at around 250–350
mM,24–27 which we confirmed by 23Na MRI imaging (Figure 3B).
Secondly, we identified a potential gradient of sodium between
the territorial/interterritorial matrix and PCM due to absence of
aggrecan (chondroitin sulfate) in the PCM (Figure 2A). Thirdly,
all three growth factors were bound to heparan sulfate in carti-






/function/article/2/5/zqab037/6335483 by guest on 10 Septem
ber 2021
8 FUNCTION 2021, Vol. 2, No. 5.
Figure 5. Polarisation sensitive SHG measurement of collagen organisation of human articular cartilage under compressive load. (A) Full depth image of the unloaded
region of cartilage, highlighting the two areas where polarisation SHG analysis was carried out at 0% (B, F), 13% (C, G), and 21% (D, H) (representative of n = 4). These
correspond to the unloaded samples and then the overall strain in the full thickness of the cartilage. Maps of the collagen organisation in the (B–D) superficial region
and (F–H) deep region, as a function of load. The direction of the sticks indicates the collagen fibre direction and the colour of the sticks indicates I2 (level of submicron
organisation). φ2 measurements, indicating a change in orientation of collagen fibres upon compression, are shown in the (E) superficial layer and the (I) deep layer.
Blue line (0% stain), orange line (13% strain), yellow line (21% strain). Note the marked change in compression and collagen orientation in the superficial, but not deep,
region. Scale bar 100 μm.
heparin using NaCl.19,28 Our previous studies had demonstrated
that perlecan is the major heparan sulfate proteoglycan in car-
tilage and is exclusively found in the PCM.3 Though we were
unable to immunolocalise HDGF in the PCM (data not shown), it
was highly likely that it was also bound to perlecan along with
CTGF and FGF2.
Our data support a sodium dependent release of growth
factors upon injury by demonstrating that modulating sodium
directly (by exogenous NaCl addition) or indirectly (by deplet-
ing aggrecan), increases or decreases, respectively, the release
of growth factors after injury. Moreover, a shift in free sodium,
relative to bound sodium, within the tissue was demonstrated
after cartilage compression using 23Na MRI. This indicates that
pathological type mechanical loading (28% unconfined strain)
leads to a relative increase in free sodium levels and decrease
in the bound sodium levels.
Regional changes in sodium observed by 23Na MRI sug-
gested that sodium mobilisation occured non-uniformly in
the cartilage upon compression. This was consistent with
regional CTGF/TGFβ activation (Smad 2 phosphorylation), which
occurred just below the articular surface upon loading, and dif-
ferences in matrix stiffness. Indeed, this region of matrix had
a different polarised microscopy appearance, consistent with
the known random alignment of collagen fibres in this region,
29 and displayed reduced tissue stiffness, which became more
evident upon compression (Figure 4F). These observations were
also confirmed in human cartilage, where a marked reduction in
volume was observed in the area just below the superficial zone,
but not the deep zone, which was associated with marked col-
lagen fibre realignment (Figure 5). Our data are consistent with
previous findings that the region just below the surface is lower
in fixed charge density, 24,30 has increased permeability,31 and is
more likely to compress upon load. 30,32,33 It is also where the
tissue exhibits high cation fluxes. 34
Fluid flows away from more readily compressed regions to
unloaded regions. 35 Fluid flow is also high in osteoarthritic
tissue which loses its fixed charge density, has a lower compres-
sive modulus (more susceptible to compression) and becomes
more permeable. 36–38 However, fluid transport is not thought to
significantly affect the transport rate of small solutes in carti-
lage, as diffusion coefficients are the dominant factor for small
solute transport 39. Therefore, we suggest that displacement of
growth factors upon loading occurs as a result of the net change
in the local concentration of free sodium in the tissue rather
than due to movement of sodium mediated by fluid flow. Taken
together, we suggest that the region just below the articular sur-
face selectively loses water, causing a local increase in the con-
centration of free sodium, and this drives growth factor release
when compression is applied.
This mechanism fails in OA where severe loss of proteogly-
can leads to an inability to release growth factors upon injury.
Growth factors are still present in the tissue and can be extracted
by NaCl; indeed these appear to be increased in severe disease
compared with less diseased osteoarthritic tissue. Proteogly-
can loss and loss of fixed charge density are well established
pathological features of OA,40,41 and this is mediated by specific
aggrecan degrading enzymes such as a disintegrin and metallo-
proteinase with thrombospondin motif-5 (ADAMTS5). 22 Aggre-
canase activity is an early feature of disease and may precede
collagen degradation.42 Early partial GAG loss, when the col-
lagen network is still intact, can render cartilage more sensi-
tive to load and increased fluid loss43 suggesting that in early
disease there may be enhanced release of growth factors. This
could explain why observed release of growth factors was strong
from the less affected osteoarthritic cartilage explants (Outer-
bridge score 0–1) (Figure 6D). We were unable to test whether
this was higher than the amount released from completely nor-
mal articular cartilage, due to difficulties obtaining such tissue.
Enhancement of release early in disease might therefore rep-
resent a previously unrecognised role for aggrecanases in pro-
moting the intrinsic repair response of articular cartilage. Once
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Figure 6. Release of heparan sulfate-bound growth factors is reduced from diseased osteoarthritic tissue compared to less damaged tissue after cutting injury.
(A) Healthy and osteoarthritic human articular cartilage stained with Safranin O (scale bar = 0.2 mm). (B) Human osteochondral samples were collected from arthro-
plasty specimens and OA severity scored macroscopically according to the Outerbridge Classification (scale bar = 1cm). (C) Individual explants were digested with
proteinase K and assessed for GAG content by the dimethylmethylene blue assay. (D–G) Injury conditioned medium (15 min) was collected from osteoarthritic cartilage
samples from mildly damaged (0–1) or severely diseased (3–4) areas and immunoblotted for growth factors, (H) or assessed by ELISA (FGF2) (n = 6). (E–G) Quantifications
from D (representative image, n = 3 biological replicates). Injured cartilage explants were extracted with 2.5 M NaCl. (I) Matrix extracts was immunoblotted for growth
factor release and quantified (J–L) (representative image, n = 3 biological replicates). T-test (∗ = p<0.05, ∗∗ = p<0.01, ∗∗∗ = p<0.001).
mechanism of growth factor release and this presumably then
contributes to the failure of the tissue.
Loss of cartilage repair due to reduced growth factor bioavail-
ability is emerging as an important mechanism in OA pathogen-
esis. Both FGF2 and TGFβ have disease modifying roles in pre-
clinical models in vivo.11–13 FGF2 signalling is known to enhance
the chondrogenic potential of mesenchymal stem cells by prim-
ing them for chondrogenesis,44–46 and TGFβ drives chondro-
genic differentiation.14,15,47 Both FGF and TGFβ pathways have
been identified in OA genome wide association studies, where
hypomorphic variants are associated with increased risk of dis-
ease.48,49 Both growth factors, FGF2 and TGFβ, predict clinical
response to surgical joint distraction in OA patients; a procedure
that drives regeneration of articular cartilage.50 The therapeu-
tic potential of intrinsic growth factors is reflected in the recent
successful phase 2 FORWARD trial (NCT01919164) of a truncated
form of recombinant fibroblast growth factor 18 (sprifermin).
This study is the first structure modifying drug to demonstrate
efficacy by building back articular cartilage in OA.51,52 The role
of HDGF is currently unknown, but it has been implicated in the
tissue injury response in smooth muscle cells of vascular tissue.
53,54 Its functional role in vivo is being explored.
Our data, supported by historical studies on tissue composi-
tion, response to mechanical load and solute transport, support
a model whereby cartilage compression expels water preferen-
tially from less stiff regions of the matrix, causes an increase
in free sodium concentration, and enables the release of growth
factors from the PCM. This study identifies an important intrin-
sic repair mechanism of normal cartilage that is lost in OA, but
could be exploited to recover reparative activities to improve dis-
ease outcome.
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